Summary
Updated Aug 31, 2026
Andrew Komjathy is Chief Commercial Officer of Astria Therapeutics, Inc. (ATXS). 1 SEC Form 4 filing on record, dated 23 January 2026.
Recent Transactions
3Every recent SEC Form 4 transaction Andrew Komjathy has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Andrew Komjathy go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Andrew Komjathy's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Kevin Charles Gorman - $37.82M of NBIX open-market activity in the last 12 months
- Emily M. Leproust - $35.18M of TWST open-market activity in the last 12 months
- Tactic Pharma LLC - $35.00M of MNPR open-market activity in the last 12 months
- Roelof Botha - $34.89M of NTRA open-market activity in the last 12 months
- Nello Mainolfi - $34.88M of KYMR open-market activity in the last 12 months
- James C. Foster - $34.84M of CRL open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Andrew Komjathy?
Andrew Komjathy is a corporate insider, tracked as Chief Commercial Officer of Astria Therapeutics, Inc. (ATXS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Andrew Komjathy last file a Form 4?
The only primary Form 4 on record is dated 23 January 2026.
Where can I see all of Andrew Komjathy's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Andrew Komjathy and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial